Inventor
COLLINS MICHAEL RAYMOND
US17 patents
⚠️ This page may combine multiple inventors who share the name “COLLINS MICHAEL RAYMOND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
10 patentsUS8680111B2Mar 25, 2014
Macrocyclic derivatives for the treatment of diseases
PFIZER54 citations96
US9133215B2Sep 15, 2015
Macrocyclic derivatives for the treatment of diseases
PFIZER16 citations82
US10570121B2Feb 25, 2020
Substituted dihydroisoquinolinone compounds
PFIZER2 citations72
US10125130B2Nov 13, 2018
Cycloalkyl-linked diheterocycle derivatives
PFIZER2 citations71
US10662204B2May 26, 2020
Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
PFIZER4 citations70
US10590115B2Mar 17, 2020
Tetrahydroquinazoline derivatives useful as anticancer agents
PFIZER2 citations70
US10676471B2Jun 9, 2020
Cycloalkyl-linked diheterocycle derivatives
PFIZER0 citations50
US9873690B2Jan 23, 2018
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER1 citations49
US10544095B2Jan 28, 2020
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER0 citations38
US9593097B2Mar 14, 2017
Axl inhibitors
PFIZER0 citations38
AGOURON PHARMA
5 patentsUS6884890B2Apr 26, 2005
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA178 citations98
US6534524B1Mar 18, 2003
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA277 citations98
US6635641B2Oct 21, 2003
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA83 citations95
US7141587B2Nov 28, 2006
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA17 citations92
US6891044B2May 10, 2005
Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
AGOURON PHARMA20 citations92